Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Mar 4, 2014

30071_dirs_2014-03-04_36816dc1-0c45-4fb9-a1b2-01f953496e6e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-02-28

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-28 ResMed Common Stock S 7500 $44.50 Disposed 84988 Direct
2014-02-28 ResMed Common Stock S 7500 $44.65 Disposed 234900 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 136000 Indirect
ResMed Common Stock 23200 Indirect